Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New PTPN11 inhibitors identified at Medshine Discovery

Aug. 25, 2021

Bristol Myers Squibb identifies new lead BRD4 inhibitors

Aug. 24, 2021

Foghorn initiates first-in-human study of FHD-609 for synovial sarcoma

Aug. 24, 2021

H3.3-K27M drives tumorigenesis in hindbrain NSCs through disruption of PRC2 and enhancer functions

Aug. 24, 2021

Small-molecule degrader targets phospho-AKT and inhibits growth of PI3K/PTEN pathway mutant cancers

Aug. 24, 2021

Rhenium-labeled nanoliposomes show efficacy in rat models of leptomeningeal disease

Aug. 24, 2021

Icahn School of Medicine at Mount Sinai presents new arylsulfonamide derivatives

Aug. 24, 2021

New SUMO-activating enzyme subunit 1 inhibitors identified at Oncovalent Therapeutics

Aug. 24, 2021

Cytokine-induced JAK/STAT signaling plays role in cachexia

Aug. 23, 2021

FDA clears IND for clinical trials of siroquine for newly diagnosed GBM

Aug. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.